|
End-of-day quote
Shenzhen S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 6.230 CNY | +1.14% |
|
-2.50% | -21.64% |
| Market Cap | 3.82B 572M 511M 472M 428M 801M 54.35B 814M 5.68B 2.25B 28.47B 2.15B 2.1B 89.77B | P/E 2024 |
96.5x | P/E 2025 | 91.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.16B 174M 155M 144M 130M 243M 16.52B 247M 1.73B 684M 8.66B 653M 639M 27.3B | EV / Sales 2024 |
0.5x | EV / Sales 2025 | 0.72x |
| Free-Float |
48.55% | Yield 2024 |
1.52% | Yield 2025 | 1.26% |
| 1 day | +1.14% | ||
| 1 week | -2.50% | ||
| Current month | -4.15% | ||
| 1 month | -2.96% | ||
| 3 months | +3.66% | ||
| 6 months | -15.35% | ||
| Current year | -21.64% |
| 1 week | 5.97 |  | 6.44 |
| 1 month | 5.97 | | 6.7 |
| Current year | 5.67 | | 9.8 |
| 1 year | 5.67 | | 9.8 |
| 3 years | 5.38 | | 10.13 |
| 5 years | 5.38 | | 12 |
| 10 years | 5.38 | | 14.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hai Chen
CEO | Chief Executive Officer | 46 | 2022-07-07 |
Jian Wang
PRN | Corporate Officer/Principal | 53 | 2019-04-25 |
Ming Yi Jia
PRN | Corporate Officer/Principal | 53 | 2020-08-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Yang Wang
BRD | Director/Board Member | 48 | 2023-06-27 |
Sheng Chen
CHM | Chairman | 57 | 2023-06-27 |
Yan Ping Gao
BRD | Director/Board Member | 63 | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | -2.50% | -12.62% | -19.82% | 581M | |
| +0.76% | +1.31% | +54.27% | +117.14% | 1,135B | |
| +2.51% | +3.23% | +38.56% | +74.05% | 635B | |
| +1.18% | +0.08% | +25.29% | +96.64% | 505B | |
| +1.34% | +3.92% | +47.72% | +66.49% | 378B | |
| -0.49% | -0.47% | +66.04% | +40.18% | 358B | |
| -0.88% | +2.35% | +23.23% | +49.39% | 295B | |
| +0.33% | +3.60% | +2.39% | +23.61% | 266B | |
| +1.43% | +1.57% | +50.56% | +61.40% | 237B | |
| +1.80% | -0.10% | +29.02% | +99.06% | 193B | |
| Average | +0.88% | +1.31% | +32.44% | +60.82% | 400.42B | |
| Weighted average by Cap. | +0.93% | +1.63% | +41.38% | +80.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.28B 492M 439M 406M 368M 688M 46.7B 699M 4.88B 1.93B 24.47B 1.85B 1.81B 77.14B | 3.2B 479M 428M 395M 358M 670M 45.5B 682M 4.76B 1.88B 23.84B 1.8B 1.76B 75.16B |
| Net income | 40.41M 6.06M 5.41M 5M 4.53M 8.47M 575M 8.61M 60.14M 23.81M 301M 22.74M 22.25M 950M | 53.91M 8.08M 7.22M 6.67M 6.04M 11.31M 767M 11.49M 80.24M 31.77M 402M 30.33M 29.69M 1.27B |
| Net Debt | -2.45B -368M -328M -303M -275M -514M -34.91B -523M -3.65B -1.45B -18.29B -1.38B -1.35B -57.67B | -2.66B -398M -356M -329M -298M -557M -37.82B -566M -3.96B -1.57B -19.82B -1.5B -1.46B -62.47B |
Employees
5,716
Sector
Pharmaceuticals
Calendar
03:00am
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | CN¥6.140 | -1.44% | 11,156,700 |
| 26-10-23 | CN¥6.230 | +1.14% | 11,626,502 |
| 26-10-22 | CN¥6.160 | -2.38% | 10,617,799 |
| 26-10-21 | CN¥6.310 | +0.96% | 6,943,400 |
| 26-10-20 | CN¥6.250 | -0.95% | 7,653,201 |
- Stock Market
- Stocks
- 000919 Stock
Select your edition
All financial news and data tailored to specific country editions
